DE2555516A1 - 20-alkoxy-16-alkylprostadiensaeurederivate - Google Patents

20-alkoxy-16-alkylprostadiensaeurederivate

Info

Publication number
DE2555516A1
DE2555516A1 DE19752555516 DE2555516A DE2555516A1 DE 2555516 A1 DE2555516 A1 DE 2555516A1 DE 19752555516 DE19752555516 DE 19752555516 DE 2555516 A DE2555516 A DE 2555516A DE 2555516 A1 DE2555516 A1 DE 2555516A1
Authority
DE
Germany
Prior art keywords
mixture
methyl
methoxy
trans
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752555516
Other languages
German (de)
English (en)
Inventor
Noriyoshi Inukai
Yoshio Ishii
Hidenori Iwamoto
Masuo Murakami
Tetsuya Shiozaki
Toshinari Tamura
Kenichi Tomioka
Isao Yanagisawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49145617A external-priority patent/JPS5810383B2/ja
Priority claimed from JP13229575A external-priority patent/JPS5257145A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE2555516A1 publication Critical patent/DE2555516A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19752555516 1974-12-20 1975-12-10 20-alkoxy-16-alkylprostadiensaeurederivate Withdrawn DE2555516A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP49145617A JPS5810383B2 (ja) 1974-12-20 1974-12-20 シンキナ １６− アルキル −２０− アルコキシプロスタジエンサンユウドウタイノ セイホウ
JP13229575A JPS5257145A (en) 1975-11-04 1975-11-04 Process for preparing novel alkyl 16_alkyl-20-alkoxyprostadienate deri vatives

Publications (1)

Publication Number Publication Date
DE2555516A1 true DE2555516A1 (de) 1976-07-01

Family

ID=26466912

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752555516 Withdrawn DE2555516A1 (de) 1974-12-20 1975-12-10 20-alkoxy-16-alkylprostadiensaeurederivate

Country Status (7)

Country Link
US (2) US4055589A (en, 2012)
DE (1) DE2555516A1 (en, 2012)
DK (1) DK142235B (en, 2012)
ES (1) ES443720A1 (en, 2012)
FR (1) FR2294695A1 (en, 2012)
GB (1) GB1535217A (en, 2012)
SE (1) SE410313B (en, 2012)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
JP3209427B2 (ja) * 1992-02-07 2001-09-17 科研製薬株式会社 創傷または痔疾治療剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (en, 2012) * 1970-06-10 1975-02-04
JPS5432773B2 (en, 2012) * 1972-05-09 1979-10-16
NL7209738A (en) * 1972-07-13 1974-01-15 Alkenyl succinic anhydrides - useful as washing agent builders
GB1488006A (en) * 1974-02-13 1977-10-05 Ono Pharmaceutical Co Prostaglandin analogues
DE2416193C2 (de) * 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel

Also Published As

Publication number Publication date
DK142235B (da) 1980-09-29
SE410313B (sv) 1979-10-08
SE7514434L (sv) 1976-06-21
DK142235C (en, 2012) 1981-02-23
US4055589A (en) 1977-10-25
ES443720A1 (es) 1977-08-16
DK541575A (en, 2012) 1976-01-21
FR2294695B1 (en, 2012) 1979-09-28
FR2294695A1 (fr) 1976-07-16
US4246280A (en) 1981-01-20
GB1535217A (en) 1978-12-13

Similar Documents

Publication Publication Date Title
DE2927715C2 (en, 2012)
EP0054168A1 (de) 1,1,2-Triphenyl-but-1-en-Derivate sowie Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CH636096A5 (de) Bicyclische prostaglandine, verfahren zu ihrer herstellung und pharmazeutische praeparate.
DE2365035C2 (de) trans-Δ↑2↑-Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
DE2409460A1 (de) Prostaglandinverbindungen und verfahren zu ihrer herstellung
EP0029247A1 (de) Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
DE2831761A1 (de) 2,3,6-substituierte-4-pyronderivate und ihre verwendung
DE2555516A1 (de) 20-alkoxy-16-alkylprostadiensaeurederivate
DE1956290A1 (de) Neue,prostaglandinartige Verbindungen und Verfahren zu ihrer Herstellung
DE2825855C3 (de) 15-substituierte-ι-Pentanorprostaglandin-derivate
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2825440C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE2440919A1 (de) Prostaglandinanaloge, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
CH639950A5 (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten.
DE2221301A1 (de) Prostaglandin-Analoge und Verfahren zu ihrer Herstellung
DE3104785A1 (de) Basische ether der 4-hydroxy-benzophenone, die als (beta)-blocker wirksam sind, und verfahren zu ihrer herstellung
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine
EP0034746B1 (de) 5-Sulfamoyl-orthanilsäuren, Verfahren zu ihrer Herstellung, diese enthaltende Heilmittel und die Verbindungen zur Verwendung als Heilmittel
CH632743A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit einer 4,5-doppelbindung.
CH629772A5 (en) Process for the preparation of optically active 8-azaprostanoic acid derivatives
DE2508251A1 (de) Neue derivate des indols, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
EP0029527A2 (de) Prostaglandinderivate in der 6-Keto-PGA1-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln und ihre Zwischenprodukte
DE2612114A1 (de) Prostaglandin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
DE2701455A1 (de) Neue cyclopentanverbindungen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee